Loading...

Johnson & Johnson

JNJNYSE
Healthcare
Drug Manufacturers - General
$168.30
$-1.26(-0.74%)

Fundamental Analysis of Johnson & Johnson (JNJ)

Comprehensive financial metrics and ratios analysis
EPS (TTM)
$9.34
P/E Ratio
18.02
ROE
0.30%
Net Margin
0.25%

Key Financial Metrices

Valuation Metrics

4 metrics
Market CapTotal market value of outstanding shares
$405.04B
Shares OutstandingTotal number of shares issued
$2.41B
Book Value/ShareNet worth per share
$32.44
Revenue/ShareAnnual revenue per share
$37.46

Profitability Metrics

6 metrics
EPS (TTM)Earnings per share trailing twelve months
$9.34
Net MarginNet income as percentage of revenue
25.005%
Operating MarginOperating income as percentage of revenue
24.42%
ROEReturn on shareholders' equity
30.39%
ROAReturn on total assets
11.72%
ROCEReturn on capital employed
15.90%

Cash Flow Metrics

3 metrics
Free Cash Flow/ShareCash generated per share after capex
$6.93
Cash/ShareCash and equivalents per share
$7.80
FCF YieldFree cash flow as percentage of market cap
4.14%

Dividend Metrics

2 metrics
Dividend/ShareAnnual dividend payment per share
$5.02
Dividend YieldAnnual dividend as percentage of stock price
2.98%
Financial Ratios Analysis data is not available for JNJFinancial Ratios Analysis details for JNJ are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Sector Benchmarking data is not available for JNJSector Benchmarking details for JNJ are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Johnson & Johnson Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Johnson & Johnson. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Johnson & Johnson's unique business strengths and challenges.

Key Financial Metrics for Johnson & Johnson

For Johnson & Johnson, essential financial indicators include EPS 9.34, PE 18.02, and ROE 0.30. These key ratios reveal insights into Johnson & Johnson's profitability, valuation, and operational health. Understanding these metrics enables you to compare Johnson & Johnson with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Johnson & Johnson

Metrics like Net Margin 25.005% and ROA 11.72% shed light on how well Johnson & Johnson is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Johnson & Johnson can sustain its operations and continue growing in the future.

Valuation and Market Position of Johnson & Johnson

Using ratios such as P/B Ratio 5.19 and PEG Ratio 4.79, investors can assess whether Johnson & Johnson is appropriately valued based on its financials and growth potential. These figures, combined with Johnson & Johnson's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Johnson & Johnson

Financial health indicators, such as Debt/Equity Ratio 0.15 and Cash Flow $6.93, provide a snapshot of Johnson & Johnson's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Johnson & Johnson, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Johnson & Johnson

Investing in Johnson & Johnson based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Johnson & Johnson focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;